Joseph Romagnuolo to Cost-Benefit Analysis
This is a "connection" page, showing publications Joseph Romagnuolo has written about Cost-Benefit Analysis.
Connection Strength
0.540
-
Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer. 2008 Jan 01; 112(1):222.
Score: 0.256
-
Double plastic stents for distal malignant biliary obstruction: preliminary evidence for a novel cost-effective alternative to metal stenting. Am J Gastroenterol. 2014 Feb; 109(2):295-7.
Score: 0.098
-
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1207-14.
Score: 0.055
-
Noninvasive vs. selective invasive biliary imaging for acute biliary pancreatitis: an economic evaluation by using decision tree analysis. Gastrointest Endosc. 2005 Jan; 61(1):86-97.
Score: 0.052
-
Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. Ann Surg. 2002 Aug; 236(2):191-202.
Score: 0.044
-
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013 Mar; 108(3):410-5.
Score: 0.023
-
Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province. Can J Gastroenterol. 2004 Oct; 18(10):619-24.
Score: 0.013